2alv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
|ACTIVITY=
|ACTIVITY=
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2alv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2alv OCA], [http://www.ebi.ac.uk/pdbsum/2alv PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2alv RCSB]</span>
}}
}}
Line 32: Line 35:
[[Category: Santarsiero, B D.]]
[[Category: Santarsiero, B D.]]
[[Category: Xi, K.]]
[[Category: Xi, K.]]
-
[[Category: CY6]]
 
[[Category: 3c]]
[[Category: 3c]]
[[Category: 3cl]]
[[Category: 3cl]]
Line 43: Line 45:
[[Category: sar]]
[[Category: sar]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 15:51:11 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 01:54:22 2008''

Revision as of 22:54, 30 March 2008


PDB ID 2alv

Drag the structure with the mouse to rotate
, resolution 1.90Å
Ligands:
Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



X-ray structural analysis of SARS coronavirus 3CL proteinase in complex with designed anti-viral inhibitors


Overview

Design, synthesis, and biological evaluation of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease (SARS-3CLpro) inhibitors for severe acute respiratory syndrome coronavirus (SARS-CoV) are described. These inhibitors exhibited antiviral activity against SARS-CoV in infected cells in the micromolar range. An X-ray crystal structure of our lead inhibitor (4) bound to SARS-3CLpro provided important drug-design templates for the design of small-molecule inhibitors.

About this Structure

2ALV is a Single protein structure of sequence from Human sars coronavirus. Full crystallographic information is available from OCA.

Reference

Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors., Ghosh AK, Xi K, Ratia K, Santarsiero BD, Fu W, Harcourt BH, Rota PA, Baker SC, Johnson ME, Mesecar AD, J Med Chem. 2005 Nov 3;48(22):6767-71. PMID:16250632

Page seeded by OCA on Mon Mar 31 01:54:22 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools